HUP0303758A3 - Heterocyclylalkyl piperidine derivatives and their preparation and pharmaceutical compositions containing them - Google Patents

Heterocyclylalkyl piperidine derivatives and their preparation and pharmaceutical compositions containing them

Info

Publication number
HUP0303758A3
HUP0303758A3 HU0303758A HUP0303758A HUP0303758A3 HU P0303758 A3 HUP0303758 A3 HU P0303758A3 HU 0303758 A HU0303758 A HU 0303758A HU P0303758 A HUP0303758 A HU P0303758A HU P0303758 A3 HUP0303758 A3 HU P0303758A3
Authority
HU
Hungary
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
piperidine derivatives
heterocyclylalkyl piperidine
Prior art date
Application number
HU0303758A
Other languages
English (en)
Original Assignee
Novexel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novexel filed Critical Novexel
Publication of HUP0303758A2 publication Critical patent/HUP0303758A2/hu
Publication of HUP0303758A3 publication Critical patent/HUP0303758A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
HU0303758A 2000-11-15 2001-11-14 Heterocyclylalkyl piperidine derivatives and their preparation and pharmaceutical compositions containing them HUP0303758A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0014738A FR2816618B1 (fr) 2000-11-15 2000-11-15 Derives heterocyclylalcoyl piperidine, leur preparation et les compositions qui les contiennent
PCT/FR2001/003559 WO2002040474A2 (fr) 2000-11-15 2001-11-14 Derives heterocyclylalcoyl piperidine et leur application comme antimicrobiens

Publications (2)

Publication Number Publication Date
HUP0303758A2 HUP0303758A2 (hu) 2004-03-01
HUP0303758A3 true HUP0303758A3 (en) 2009-08-28

Family

ID=8856503

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303758A HUP0303758A3 (en) 2000-11-15 2001-11-14 Heterocyclylalkyl piperidine derivatives and their preparation and pharmaceutical compositions containing them

Country Status (28)

Country Link
EP (2) EP1695964A1 (hu)
JP (1) JP2004514661A (hu)
KR (1) KR100849608B1 (hu)
CN (1) CN1483031A (hu)
AR (1) AR034006A1 (hu)
AT (1) ATE337311T1 (hu)
AU (2) AU2002218365B2 (hu)
BG (1) BG107793A (hu)
BR (1) BR0115312A (hu)
CA (1) CA2429311A1 (hu)
CZ (1) CZ20031316A3 (hu)
DE (1) DE60122567T2 (hu)
DK (1) DK1337529T3 (hu)
EA (1) EA200300568A1 (hu)
EE (1) EE200300207A (hu)
ES (1) ES2271119T3 (hu)
FR (1) FR2816618B1 (hu)
HR (1) HRP20030379A2 (hu)
HU (1) HUP0303758A3 (hu)
IL (1) IL155841A0 (hu)
NO (2) NO20032187L (hu)
PL (1) PL363004A1 (hu)
PT (1) PT1337529E (hu)
SK (1) SK5822003A3 (hu)
TN (1) TNSN01160A1 (hu)
WO (1) WO2002040474A2 (hu)
YU (1) YU46803A (hu)
ZA (1) ZA200303794B (hu)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6962917B2 (en) 2000-07-26 2005-11-08 Smithkline Beecham P.L.C. Aminopiperidine quinolines and their azaisosteric analogues with antibacterical activity
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
GB0112836D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0118238D0 (en) * 2001-07-26 2001-09-19 Smithkline Beecham Plc Medicaments
EP2181996A1 (en) 2002-01-29 2010-05-05 Glaxo Group Limited Aminopiperidine derivatives
JP4508650B2 (ja) 2002-01-29 2010-07-21 グラクソ グループ リミテッド アミノピペリジン化合物、当該化合物の製法および当該化合物を含有する医薬組成物
TW200406413A (en) 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
AR040336A1 (es) 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
FR2842807A1 (fr) * 2002-07-23 2004-01-30 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, procede et intermediaires de preparation et compositions les renfermant
GB0217294D0 (en) * 2002-07-25 2002-09-04 Glaxo Group Ltd Medicaments
FR2844270B1 (fr) * 2002-09-11 2006-05-19 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent
FR2844268B1 (fr) * 2002-09-11 2004-10-22 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent
DE10256405A1 (de) * 2002-12-02 2004-06-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen, die Topoisomerase IV inhibieren
US7232832B2 (en) 2002-11-05 2007-06-19 Smithkline Beecham Corporation Antibacterial agents
US7491714B2 (en) 2002-12-04 2009-02-17 Glaxo Group Limited Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
FR2852954B1 (fr) * 2003-03-28 2006-07-14 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
US7232833B2 (en) 2003-03-28 2007-06-19 Novexel 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
FR2862301B1 (fr) * 2003-11-17 2007-12-21 Aventis Pharma Sa Nouveau procede de preparation de quinoleines 3-fluorees
FR2867472B1 (fr) * 2004-03-12 2008-07-18 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
EP1846416A4 (en) 2005-01-25 2009-07-01 Glaxo Group Ltd ANTIBACTERIAL AGENTS
US7592334B2 (en) 2005-01-25 2009-09-22 Glaxo Group Limited Antibacterial agents
WO2006081264A1 (en) 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
WO2006081179A1 (en) 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
AU2006218661A1 (en) 2005-03-01 2006-09-08 Wyeth Cinnoline compounds and their use as liver X receptor modilators
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
CN101374831B (zh) 2006-01-26 2011-04-27 埃科特莱茵药品有限公司 四氢吡喃抗生素
DE602007009205D1 (de) 2006-04-06 2010-10-28 Glaxo Group Ltd Pyrrolochinoxalinonderivate als antibakterielle mittel
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
TWI414290B (zh) 2007-06-15 2013-11-11 Actelion Pharmaceuticals Ltd 3-胺基-6-(1-胺基-乙基)-四氫哌喃衍生物
EP2080761A1 (en) 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
WO2010043714A1 (en) 2008-10-17 2010-04-22 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
JP5653935B2 (ja) 2009-01-15 2015-01-14 グラクソ グループ リミテッドGlaxo Group Limited 抗菌薬として有用なナフチリジン―2(1h)−オン化合物
KR20150043465A (ko) * 2012-08-15 2015-04-22 글락소 그룹 리미티드 화학 공정
CN106659717B (zh) 2014-08-22 2019-09-06 葛兰素史密斯克莱知识产权发展有限公司 用于治疗淋病奈瑟球菌感染的三环含氮化合物
WO2016138988A1 (en) * 2015-03-02 2016-09-09 University Of Copenhagen Piperazine inhibitors of bacterial gyrase and topoisomerase iv
TW201722965A (zh) 2015-08-16 2017-07-01 葛蘭素史密斯克藍智慧財產發展有限公司 用於抗菌應用之化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7908031A (nl) 1979-11-01 1981-06-01 Acf Chemiefarma Nv Nieuwe chinolinederivaten en farmaceutische preparaten die een dergelijke verbinding bevatten, alsmede werk- wijze voor het bereiden van deze verbindingen.
JPH0239546A (ja) 1988-07-29 1990-02-08 Origin Electric Co Ltd 混成集積回路の製造方法
AU623474B2 (en) 1989-01-16 1992-05-14 Laboratoire Roger Bellon New benzo(1,8)naphthyridine derivatives, their preparation and compositions containing them
DE69908555T2 (de) * 1998-01-26 2004-05-06 Smithkline Beecham P.L.C., Brentford Chinolinderivate als antibakterielles arzneimittel
WO2000043383A1 (en) * 1999-01-20 2000-07-27 Smithkline Beecham P.L.C. Piperidinylquinolines as protein tyrosine kinase inhibitors
FR2852954B1 (fr) * 2003-03-28 2006-07-14 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
AR034006A1 (es) 2004-01-21
ZA200303794B (en) 2004-06-29
EP1337529B1 (fr) 2006-08-23
WO2002040474A2 (fr) 2002-05-23
FR2816618A1 (fr) 2002-05-17
DE60122567T2 (de) 2007-08-23
AU2002218365B2 (en) 2007-07-05
FR2816618B1 (fr) 2002-12-27
DE60122567D1 (de) 2006-10-05
HRP20030379A2 (en) 2005-04-30
AU1836502A (en) 2002-05-27
KR100849608B1 (ko) 2008-07-31
CA2429311A1 (en) 2002-05-23
KR20030060934A (ko) 2003-07-16
IL155841A0 (en) 2003-12-23
NO20032187D0 (no) 2003-05-14
SK5822003A3 (en) 2004-06-08
PL363004A1 (en) 2004-11-15
ES2271119T3 (es) 2007-04-16
EP1337529A2 (fr) 2003-08-27
NO20072142L (no) 2007-04-25
CN1483031A (zh) 2004-03-17
BR0115312A (pt) 2003-09-23
HUP0303758A2 (hu) 2004-03-01
PT1337529E (pt) 2006-12-29
YU46803A (sh) 2006-05-25
BG107793A (bg) 2004-08-31
ATE337311T1 (de) 2006-09-15
DK1337529T3 (da) 2006-12-18
WO2002040474A3 (fr) 2002-10-31
NO20032187L (no) 2003-06-26
CZ20031316A3 (cs) 2003-10-15
EE200300207A (et) 2003-08-15
JP2004514661A (ja) 2004-05-20
TNSN01160A1 (fr) 2005-11-10
EP1695964A1 (fr) 2006-08-30
EA200300568A1 (ru) 2003-12-25

Similar Documents

Publication Publication Date Title
HUP0303758A3 (en) Heterocyclylalkyl piperidine derivatives and their preparation and pharmaceutical compositions containing them
IL152718A0 (en) Piperidine derivatives and pharmaceutical compositions containing the same
IL151209A0 (en) Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation
DZ3313A1 (fr) Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
HUP0400636A3 (en) Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
HUP0303835A3 (en) Anti-allergic piperidine compounds, their use and pharmaceutical compositions containing them
HUP0301391A3 (en) Piperazine and piperidine derivatives pharmaceutical compositions containing them and their use
HUP0302550A3 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines and pharmaceutical compositions containing them
AU9025701A (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containingthe same
HUP0400837A3 (en) 2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them
HUP0204283A3 (en) Piperidine quinolyl propyl derivatives, preparation method and pharmaceutical compositions containing same
HUP0204474A3 (en) 1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use
HUP0400551A2 (en) Piperazine derivatives, their preparation and pharmaceutical compositions containing them
HUP0300534A3 (en) Antitumoral ecteinascidin derivatives and pharmaceutical compositions containing them
HUP0301713A3 (en) Pharmaceutical compositions containing propenone derivatives and their use
IL151912A0 (en) Pyrolidine derivatives, their preparation and pharmaceutical compositions containing them
HUP0303184A3 (en) Substituted c-cyclohexylmethylamine derivatives and pharmaceutical compositions containing them
HUP0204354A3 (en) Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same and their use
HUP0303673A3 (en) Piperidine derivatives and pharmaceutical compositions containing these derivatives as the active ingredient
HUP0303204A3 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing them
IL159219A0 (en) Pyrrolidine oxadiazole derivatives, their preparation and pharmaceutical compositions containing them
IL151832A0 (en) Pharmaceutical compositions containing oligosaccharides and preparation thereof
IL151715A0 (en) N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them
HUP0203383A3 (en) Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
HUP0201443A3 (en) 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: NOVEXEL, FR

Free format text: FORMER OWNER(S): AVENTIS PHARMA S.A., FR

FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished